Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saif Huda

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|May 8, 2024
A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppressionInga Koneczny, Marina Mané-Damas, Shenghua Zong, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody diseaseItay Lotan, John J Chen, Yael Hacohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disordersValentina Damato, Jakob Theorell, Adam Al-Diwani, et al.
Journal of Autoimmunity|December 15, 2016
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patientsInga Koneczny, Jo A A Stevens, Anna De Rosa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 VaccinationAnna G Francis, Kariem Elhadd, Valentina Camera, et al.
JAMA Network Open|January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United KingdomChanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 15, 2025
Treatment response in children with relapsing MOG-antibody associated diseaseEva-Maria Wendel, John J Chen, Annikki Bertolini, et al.
Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|May 8, 2024
A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppressionInga Koneczny, Marina Mané-Damas, Shenghua Zong, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody diseaseItay Lotan, John J Chen, Yael Hacohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disordersValentina Damato, Jakob Theorell, Adam Al-Diwani, et al.
Journal of Autoimmunity|December 15, 2016
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patientsInga Koneczny, Jo A A Stevens, Anna De Rosa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 VaccinationAnna G Francis, Kariem Elhadd, Valentina Camera, et al.
JAMA Network Open|January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United KingdomChanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 15, 2025
Treatment response in children with relapsing MOG-antibody associated diseaseEva-Maria Wendel, John J Chen, Annikki Bertolini, et al.
Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Pageof 8